Desq Long
Sign in
SEC FORM 4
$2,700.72

Nurix Therapeutics, Inc. (NRIX)

Acquisition (code M) of 1,452 shares at $1.86 per share.

Reporting Person Hansen Gwenn · Officer Title Chief Scientific Officer · Transaction Code M

Traded Sep 1, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001817160-26-000019 · filed 2026-09-01 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Nurix Therapeutics, Inc. (NRIX)." Disclosed 2026-09-01. https://desqlong.com/cards/0001817160-26-000019-1 (retrieved 2026-09-26).